A detailed history of Vestal Point Capital, LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Vestal Point Capital, LP holds 900,000 shares of JAZZ stock, worth $107 Million. This represents 7.6% of its overall portfolio holdings.

Number of Shares
900,000
Previous 1,500,000 40.0%
Holding current value
$107 Million
Previous $160 Billion 37.37%
% of portfolio
7.6%
Previous 11.94%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.57 - $116.37 $60.3 Million - $69.8 Million
-600,000 Reduced 40.0%
900,000 $100 Billion
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $41.6 Million - $47.6 Million
400,000 Added 36.36%
1,500,000 $160 Billion
Q1 2024

May 13, 2024

BUY
$115.19 - $132.77 $43.2 Million - $49.8 Million
375,000 Added 51.72%
1,100,000 $132 Billion
Q4 2023

Feb 13, 2024

BUY
$114.26 - $136.0 $82.8 Million - $98.6 Million
725,000 New
725,000 $89.2 Billion

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.47B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.